What is Melanotan II?
Melanotan II is a synthetic analog of α-MSH promoted for skin tanning and libido. It is not approved by the FDA or, to our knowledge, any major regulator.
What the evidence shows
Melanotan II is unapproved and has been associated in reports with nausea, blood-pressure changes, and effects on moles/melanocytes; regulators in several countries have warned against it. Its FDA review is scheduled for the separate meeting before the end of February 2027.
Is it legal?
Melanotan II is not FDA-approved. In April 2026 it was removed from FDA Category 2 but not moved to the approved Category 1 list, so legal compounding is not authorized; the PCAC reviews it on before end of Feb 2027.
Will Melanotan II become legal in 2026?+
Is “research-grade” Melanotan II the same as a medicine?+
Primary sources: FDA 503A interim list (Apr 2026 update) · FDA Advisory Committee Calendar; Federal Register docket FDA-2025-N-6895.
Medical & editorial disclaimer. This article is independent reference information, not medical advice and not a recommendation to use any substance. Melanotan II is not FDA-approved. Nothing here should be used to obtain, prepare, or self-administer any drug. Talk to a licensed clinician about your health. Peptide Docket is not affiliated with the FDA and does not sell peptides.